Treatment Details – 10.6 months

Survival: 10.6 months
Toxicity Grade:4
Treatments: Chemotherapy
Drugs: Navelbine
Country:United Kingdom
Hospital:St Bartholomew’s Hospital
Date: 12/2000

Patients: This Phase II study involved 29 patients with malignant pleural mesothelioma.

Treatment: The treatment consisted of administration of the chemotherapy drug, vinorelbine (navelbine).

Toxicity: Grade 3-4 toxicities included neutropenia, leucopenia, constipation, and phlebitis

Results: The median overall survival from the time of first treatment was 10.6 months.

Support: The authors of the study acknowledged the support of Pierre-Fabre Oncology for subsidized drug costs.

Correspondence: Jeremy P.C. Steele, MD

Get your free copy of
“Surviving Mesothelioma” Today!